Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Zealand Pharma A/S (ZEAL) News Today

Zealand Pharma A/S logo
Zealand Pharma completes enrollment in ZUPREME-1 trial
Zealand Pharma upgraded to Buy from Hold at SEB Equities
Zealand and Roche strike $5.3bn obesity treatment deal
William Blair upgrades Zealand to Outperform on recent selloff
Zealand Pharma initiated with a Market Perform at William Blair
BTIG Sticks to Its Buy Rating for Zealand Pharma (ZLDPF)
Zealand Pharma stock falls loss widens, revenue declines
Remove Ads
Get Zealand Pharma A/S News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZEAL and its competitors with MarketBeat's FREE daily newsletter.

ZEAL Media Mentions By Week

ZEAL Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ZEAL
News Sentiment

1.08

0.63

Average
Medical
News Sentiment

ZEAL News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ZEAL Articles
This Week

0

2

ZEAL Articles
Average Week

Remove Ads
Get Zealand Pharma A/S News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZEAL and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:ZEAL) was last updated on 4/6/2025 by MarketBeat.com Staff
From Our Partners